China's Biotech Industry

G

GulfLander

Brigadier
Registered Member
China’s pharmaceutical industry is booming — and Big Pharma can’t look away. From groundbreaking biotech to billion-dollar deals with the world’s largest drugmakers, China is reshaping the global medicine game faster than anyone imagined. CNA Correspondent finds out why China’s pharma industry is rising and what it means for the future of medicine and your next prescriptions.
Click to expand...
it also talked about why CN is outlicensing instead of selling medicines directly
 
Last edited:
supercat

supercat

Colonel

China Is Now a Global Drug Innovation Powerhouse. Industrial Policy Had Little to Do with It.​

INSIGHTS​

  • In 2010, China accounted for less than 8% of global clinical trials; by 2020, it had surpassed the United States in annual registered trial volume, reaching over 5,000 trials per year by 2024 — a 172% increase relative to the U.S.
  • Innovative trials targeting previously unexplored biological mechanisms rose by 49–123% relative to the U.S., and domestic Chinese firms account for 88% of the post-2015 increase.
  • The key driver was the 2016 National Reimbursement Drug List (NRDL) reform that traded drug price cuts for inclusion into China’s national insurance program, thereby massively expanding the market for innovative drugs, boosting cancer drug revenue by 500% and clinical trial activity by 86%.
  • The NRDL reform explains 43% of the surge in oncology trial activity — nearly double the combined contribution of knowledge accumulation and talent inflows from the U.S. (24%) — while industrial policies like Made in China 2025 played a negligible role.
Click to expand...
Please, Log in or Register to view URLs content!
 
supercat

supercat

Colonel
The classification of cancer based on proteomic subtypes classify tumors based on the profiles of proteins the cancer cells make rather than just genes (DNA/RNA). Nasopharyngeal carcinoma has a relatively high incidence in China. Recently, Chinese scientists classified the nasopharyngeal cancer into three proteomic subtypes for the first time, providing more specific and precise treatment options.
Please, Log in or Register to view URLs content!
Please, Log in or Register to view URLs content!
 
Last edited:
You must log in or register to reply here.
Top